In vivo effects of zoledronic acid on oral mucosal epithelial cells

E. Allam, Matthew Allen, T.M. Gabriel Chu, A. Ghoneima, L. Windsor

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: Osteonecrosis of the jaw is a serious complication of bisphosphonate treatment for which the pathophysiology is unknown. The purpose of this study was to investigate whether in vivo zoledronic acid (ZA) induces alterations in cell proliferation, apoptosis, and matrix metalloproteinases (MMPs) expression in oral mucosal epithelial cells. Methods: One-year-old dogs were either untreated (control group) or given high doses of intravenous ZA (ZA group) for 3months. The doses of ZA were equivalent to those given to cancer patients, yet were administered two times more frequently (every 2weeks). Mucosal tissues were assessed immunohistochemically for cell proliferation (proliferating cell nuclear antigen, PCNA), matrix metalloproteinase (MMP) expression, and apoptosis (caspase 3 and TUNEL). Results: There were no significant differences between the groups with respect to PCNA, MMP-2, MMP-14, and TUNEL positive cells. However, the expression of MMP-9 was significantly higher in the control group than in the ZA group (P<0.05), whereas the expression of caspase 3 was significantly lower in the control group than in the ZA group (P<0.05). Conclusion: These results suggest that high doses of ZA resulted in higher levels of apoptosis and lower levels of MMP-9 in the oral epithelial cells supporting the idea of bisphosphonate treatment affects the oral mucosa.

Original languageEnglish
Pages (from-to)291-297
Number of pages7
JournalOral Diseases
Volume17
Issue number3
DOIs
StatePublished - Apr 2011

Fingerprint

zoledronic acid
Epithelial Cells
Nuclear Matrix
Matrix Metalloproteinase 9
In Situ Nick-End Labeling
Proliferating Cell Nuclear Antigen
Diphosphonates
Apoptosis
Matrix Metalloproteinases
Caspase 3
Control Groups
Cell Proliferation
Matrix Metalloproteinase 14
Osteonecrosis
Matrix Metalloproteinase 2
Mouth Mucosa
Jaw

Keywords

  • Oral epithelial cells
  • Osteonecrosis of the jaws
  • Zoledronic acid

ASJC Scopus subject areas

  • Dentistry(all)
  • Otorhinolaryngology

Cite this

In vivo effects of zoledronic acid on oral mucosal epithelial cells. / Allam, E.; Allen, Matthew; Chu, T.M. Gabriel; Ghoneima, A.; Windsor, L.

In: Oral Diseases, Vol. 17, No. 3, 04.2011, p. 291-297.

Research output: Contribution to journalArticle

@article{7a173940db9641f3ac7b93f5e8519a96,
title = "In vivo effects of zoledronic acid on oral mucosal epithelial cells",
abstract = "Objective: Osteonecrosis of the jaw is a serious complication of bisphosphonate treatment for which the pathophysiology is unknown. The purpose of this study was to investigate whether in vivo zoledronic acid (ZA) induces alterations in cell proliferation, apoptosis, and matrix metalloproteinases (MMPs) expression in oral mucosal epithelial cells. Methods: One-year-old dogs were either untreated (control group) or given high doses of intravenous ZA (ZA group) for 3months. The doses of ZA were equivalent to those given to cancer patients, yet were administered two times more frequently (every 2weeks). Mucosal tissues were assessed immunohistochemically for cell proliferation (proliferating cell nuclear antigen, PCNA), matrix metalloproteinase (MMP) expression, and apoptosis (caspase 3 and TUNEL). Results: There were no significant differences between the groups with respect to PCNA, MMP-2, MMP-14, and TUNEL positive cells. However, the expression of MMP-9 was significantly higher in the control group than in the ZA group (P<0.05), whereas the expression of caspase 3 was significantly lower in the control group than in the ZA group (P<0.05). Conclusion: These results suggest that high doses of ZA resulted in higher levels of apoptosis and lower levels of MMP-9 in the oral epithelial cells supporting the idea of bisphosphonate treatment affects the oral mucosa.",
keywords = "Oral epithelial cells, Osteonecrosis of the jaws, Zoledronic acid",
author = "E. Allam and Matthew Allen and Chu, {T.M. Gabriel} and A. Ghoneima and L. Windsor",
year = "2011",
month = "4",
doi = "10.1111/j.1601-0825.2010.01739.x",
language = "English",
volume = "17",
pages = "291--297",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - In vivo effects of zoledronic acid on oral mucosal epithelial cells

AU - Allam, E.

AU - Allen, Matthew

AU - Chu, T.M. Gabriel

AU - Ghoneima, A.

AU - Windsor, L.

PY - 2011/4

Y1 - 2011/4

N2 - Objective: Osteonecrosis of the jaw is a serious complication of bisphosphonate treatment for which the pathophysiology is unknown. The purpose of this study was to investigate whether in vivo zoledronic acid (ZA) induces alterations in cell proliferation, apoptosis, and matrix metalloproteinases (MMPs) expression in oral mucosal epithelial cells. Methods: One-year-old dogs were either untreated (control group) or given high doses of intravenous ZA (ZA group) for 3months. The doses of ZA were equivalent to those given to cancer patients, yet were administered two times more frequently (every 2weeks). Mucosal tissues were assessed immunohistochemically for cell proliferation (proliferating cell nuclear antigen, PCNA), matrix metalloproteinase (MMP) expression, and apoptosis (caspase 3 and TUNEL). Results: There were no significant differences between the groups with respect to PCNA, MMP-2, MMP-14, and TUNEL positive cells. However, the expression of MMP-9 was significantly higher in the control group than in the ZA group (P<0.05), whereas the expression of caspase 3 was significantly lower in the control group than in the ZA group (P<0.05). Conclusion: These results suggest that high doses of ZA resulted in higher levels of apoptosis and lower levels of MMP-9 in the oral epithelial cells supporting the idea of bisphosphonate treatment affects the oral mucosa.

AB - Objective: Osteonecrosis of the jaw is a serious complication of bisphosphonate treatment for which the pathophysiology is unknown. The purpose of this study was to investigate whether in vivo zoledronic acid (ZA) induces alterations in cell proliferation, apoptosis, and matrix metalloproteinases (MMPs) expression in oral mucosal epithelial cells. Methods: One-year-old dogs were either untreated (control group) or given high doses of intravenous ZA (ZA group) for 3months. The doses of ZA were equivalent to those given to cancer patients, yet were administered two times more frequently (every 2weeks). Mucosal tissues were assessed immunohistochemically for cell proliferation (proliferating cell nuclear antigen, PCNA), matrix metalloproteinase (MMP) expression, and apoptosis (caspase 3 and TUNEL). Results: There were no significant differences between the groups with respect to PCNA, MMP-2, MMP-14, and TUNEL positive cells. However, the expression of MMP-9 was significantly higher in the control group than in the ZA group (P<0.05), whereas the expression of caspase 3 was significantly lower in the control group than in the ZA group (P<0.05). Conclusion: These results suggest that high doses of ZA resulted in higher levels of apoptosis and lower levels of MMP-9 in the oral epithelial cells supporting the idea of bisphosphonate treatment affects the oral mucosa.

KW - Oral epithelial cells

KW - Osteonecrosis of the jaws

KW - Zoledronic acid

UR - http://www.scopus.com/inward/record.url?scp=79952576447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952576447&partnerID=8YFLogxK

U2 - 10.1111/j.1601-0825.2010.01739.x

DO - 10.1111/j.1601-0825.2010.01739.x

M3 - Article

C2 - 20860766

AN - SCOPUS:79952576447

VL - 17

SP - 291

EP - 297

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 3

ER -